LEAMINGTON, Ont. - Two independent proxy advisory firms are recommending Aphria Inc. shareholders vote in favour of the cannabis company merging with Tilray Inc.
Medical marijuana is shown in Toronto on November 5, 2017. Two independent proxy advisory firms are recommending Aphria Inc. shareholders vote in favour of the cannabis company merging with Tilray Inc. THE CANADIAN PRESS/Graeme Roy
LEAMINGTON, Ont. - Two independent proxy advisory firms are recommending Aphria Inc. shareholders vote in favour of the cannabis company merging with Tilray Inc.
Institutional Shareholder Services Inc. and Glass Lewis and Co., LLC said Monday that they support the deal announced in December. The deal will see Leamington, Ont.-based Aphria receive 0.8381 shares of Nanaimo-based Tilray for each Aphria common share.